Without Concrete Evidence of Potential Infringement Liability, Petitioner Lacked Standing to Challenge PTAB’s Final Written Decision on Appeal

September 16, 2024

Reading Time : 2 min

The Federal Circuit dismissed an appeal from an inter partes review (“IPR”) final written decision for lack of standing where it found the appellant failed to provide evidence sufficient to show it suffered an injury in fact.

The appellant in this case filed an IPR petition challenging the validity of U.S. Patent No. 9,354,369 (“the ’369 Patent”) after the patentee filed two separate suits accusing the appellant’s optical filters of infringement. Ultimately, the PTAB issued a final written decision holding the appellant failed to show the challenged claims were unpatentable. Importantly, while the IPR was pending, the patentee dismissed both of its infringement lawsuits against appellant voluntarily and with prejudice.

The appellant sought review of the PTAB’s final written decision, but was immediately confronted with the threshold question of whether it had standing to appeal. Although a party does not need to establish Article III standing to appear before the PTAB, it must have standing to seek review of a PTAB decision in the Federal Circuit. And to establish standing, the appellant must show, inter alia, that it suffered an injury in fact, i.e., the appellant must allege a harm that is “concrete and particularized” and “actual or imminent, not conjectural or hypothetical.”

Here, the appellant alleged two harms: (1) supplying the filters that were the subject of one of the patentee’s dismissed lawsuits to overseas parties and (2) developing new models of filters. The Federal Circuit considered both grounds and found them insufficient to confer standing.

As to the first harm, the appellant argued it suffered an injury in fact because continuing to distribute its filters, created a likelihood that the patentee once again sue for infringement. As support, the appellant referenced a letter from the patentee stating it did not believe it was possible for the patentee to fulfill its supply agreements with non-infringing products. The court rejected this argument as too speculative because the letter was sent before the patentee filed its prior infringement lawsuits, both of which were dismissed with prejudice.

As to the second ground, the appellant submitted a declaration from its Deputy Director of Operation Management, asserting that it was continuing to develop new filters and it anticipates the patentee will accuse those products of infringement in the future. Here again, the Federal Circuit found the appellant’s alleged harm too speculative. The court noted that appellant’s declaration failed to provide detailed plans for the development of new products, any particulars about those products, or any explanation for how the products might implicate the ’369 Patent. While recognizing that a party need not concede infringement to obtain standing, the Federal Circuit maintained that the appellant’s vague and conclusory statements about future products could not meet the requirement for concrete plans for development. Because the appellant could not meet the requirements for Article III standing, the court dismissed the appeal without reaching the merits of the PTAB’s decision.

Practice Tip: Any party contemplating filing an IPR petition should carefully consider whether it will be able to meet the requirements for standing in any subsequent appeal. In the event there are doubts about standing, the risk of not being able to appeal a final written decision must be weighed against the possible benefits of filing the IPR at that point in time. Ultimately, the decision of whether to file an IPR must balance the risk of no appeal against the relative merits of the IPR and the likelihood that an IPR could be filed in the future among other factors.

Platinum Optics Technology Inc. v. Viavi Solutions Inc., C.A. No. 2023-1227 (Fed. Cir. Aug. 16, 2024).

Share This Insight

Previous Entries

IP Newsflash

June 6, 2025

In a precedential opinion, the Federal Circuit definitively held that the Patent Trial and Appeal Board has jurisdiction over IPRs that concern expired patents.

...

Read More

IP Newsflash

June 6, 2025

In a patent infringement litigation in the U.S. District Court for the Eastern District of Texas, Judge Rodney Gilstrap denied a joint motion to stay the litigation pending resolution of inter partes review when it was uncertain that all defendants would be bound by the statutory estoppel provision of 35 U.S.C. § 315(e).

...

Read More

IP Newsflash

May 30, 2025

A district court recently dismissed a patent infringement complaint for improper venue under 28 U.S.C. § 1400(b), finding that the storage and distribution of products from an Amazon warehouse was not sufficient to establish that warehouse as a regular and established place of business in the district.

...

Read More

IP Newsflash

May 27, 2025

The Federal Circuit affirmed a District of Delaware finding of non-infringement in an ANDA litigation due to the patentee’s clear and unmistakable disavowal of claim scope during prosecution. Specifically, the court held that statements made during prosecution of a parent application before the asserted claims were allowed amounted to a prosecution disclaimer that extended to subsequent patents in the family. In reaching this conclusion, the court rejected an attempt by the patentee to resurrect the claim scope through a unilateral, self-serving statement made in later applications in the family.

...

Read More

IP Newsflash

May 13, 2025

The Federal Circuit recently affirmed a district court’s holding that patent term extension (PTE) for a reissued patent was properly based on the issue date of the original patent and not that of the reissued patent. The Federal Circuit concluded that, where both the original and reissued patents claimed a drug product under regulatory review, using the issue date of the original patent to calculate PTE comports with both the purpose of the Hatch-Waxman Act and the related statutory context.

...

Read More

IP Newsflash

May 12, 2025

The Patent Trial and Appeal Board recently declined to institute a petition for IPR that was filed on the same day that the petitioner filed another petition challenging the same claims of the same patent. The board was not persuaded by petitioner’s arguments that a second petition was needed due to alleged claim construction issues or the number, length or scope differences of the challenged claims.

...

Read More

IP Newsflash

May 9, 2025

The USPTO Director vacated the board’s decision to institute inter partes review based on an erroneous application of the Fintiv factors. Specifically, the Director found that the board placed too much emphasis on Petitioner’s Sotera stipulation, and not enough emphasis on the investment in the parallel litigation. Weighing the factors as a whole, the Director determined that institution should be denied.

...

Read More

IP Newsflash

May 9, 2025

In an institution decision following the USPTO’s withdrawal of its Fintiv Memo, the board addressed discretionary denial of an IPR under Fintiv in view of a parallel ITC investigation. The board noted it would not consider the now-rescinded June 2022 memo from then-director Vidal which instructed that the PTAB would not deny institution of an IPR or PGR under Fintiv when the request is based on a parallel ITC investigation. The board conducted a Fintiv analysis in view of the ITC investigation, but ultimately determined that discretionary denial was not warranted in this particular situation.

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.